Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

Noninvasive Proportional Assist Ventilation for Acute Respiratory Insufficiency
Gay, Peter C. , Hess, Dean, Hill, Nicholas S.

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 164 | Issue: 9 | Pages: 1606-1611

10.1164/ajrccm.164.9.2011119 | PMID 11719297 Get It

Abstract Noninvasive positive pressure ventilation (NPPV) is usually applied using pressure support ventilation (PSV). Proportional assist ventilation (PAV) is a newer mode that delivers assisted ventilation in proportion to patient effort. We hypothesized that PAV for NPPV would support gas exchange and avoid intubation as well as PSV and be more comfortable and tolerable for patients. Adult patients with acute respiratory insufficiency were randomized to receive NPPV with PAV delivered using the Respironics Vision ventilator or PSV using a Puritan-Bennett 7200ae critical care ventilator. Each mode was adjusted to relieve dyspnea and improve gas exchange until patients met weaning or intubation criteria, died, or refused to continue. Twenty-one and 23 patients were entered into the PAV and PSV groups, respectively, and had similar diagnoses and baseline characteristics, although pH was slightly lower in the PAV group (7.30 versus 7.35, p = 0.02). Mortality and intubation rates were similar, but refusal rate was lower, reduction in respiratory rate was more rapid, and there were fewer complications in the PAV group. We conclude that use of the PAV mode is feasible for noninvasive therapy of acute respiratory insufficiency. Compared with PSV delivered with the Puritan-Bennett 7200ae, PAV is associated with more rapid improvements in some physiologic variables and is better tolerated.
Polymyositis–Dermatomyositis-associated Interstitial Lung Disease
Douglas, William W., Tazelaar, Henry D. , Hartman, Thomas E. , Hartman, Robert P. , Decker, Paul A. , Schroeder, Darrell R. , Ryu, Jay H. , Tazelaar, Henry D. , Decker, Paul A. , Ryu, Jay H , Schroeder, Darrell

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 164 | Issue: 7 | Pages: 1182-1185

10.1164/ajrccm.164.7.2103110 | PMID 11673206 Get It

Abstract We report findings in 70 patients with both diffuse interstitial lung disease and either polymyositis (PM) or dermatomyositis (DM). Initial presentations were most commonly either musculoskeletal (arthralgias, myalgias, and weakness) or pulmonary (cough, dyspnea, and fever) symptoms alone; in only 15 patients (21.4%) did both occur simultaneously. Pulmonary disease usually took the form of acute to subacute antibiotic-resistant community-acquired pneumonia. Chest radiographs and computed tomography most commonly demonstrated bilateral irregular linear opacities involving the lung bases; occasionally consolidation was present. Jo-1 antibody was present in 19 (38%) of 50 patients tested. Synchronous associated malignancy was present in 4 of 70 patients (5.7%). Surgical lung biopsies disclosed nonspecific interstitial pneumonia (NSIP) in 18 of 22 patients (81.8%), organizing diffuse alveolar damage (DAD) in 2, bronchiolitis obliterans organizing pneumonia (BOOP) in 1, and usual interstitial pneumonia (UIP) in 1. Treatment usually included prednisone in 40–60 mg/d dosages for initial control, followed by lower dose prednisone plus an immunosuppressive agent such as azathioprine or methotrexate for disease suppression. Survival was significantly better than that observed for historical control subjects with idiopathic UIP, and was more consistent with survival previously reported in idiopathic NSIP. There was no difference in survival between Jo-1 positive and Jo-1 negative groups.
Idiopathic Pulmonary Fibrosis
King, Talmadge E. , Schwarz, Marvin I., Brown, Kevin M. , Colby, Thomas V. , Waldron, James A., Flint, Andrew , Thurlbeck, William M., Cherniack, Reuben M., Tooze, Janet Austin

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 164 | Issue: 6 | Pages: 1025-1032

10.1164/ajrccm.164.6.2001056 | PMID 11587991 Get It

Abstract It is hypothesized that the extent and severity of fibrosis and cellularity found on lung biopsy determine the prognosis and response to therapy in idiopathic pulmonary fibrosis (IPF). The objective of this study was to determine which histopathologic features predict survival in IPF. We prospectively studied 87 patients with usual interstitial pneumonia (UIP) confirmed by surgical lung biopsy. Four pathologists independently graded the extent and severity of specific histopathologic features. We used Cox proportional-hazards models to assess the effect of histopathologic patterns on patients' survival. The effects of age, sex, and smoking were also included in the analysis. Sixty-three patients died during the 17-yr study period. Survival was longer in subjects with lesser degrees of granulation/connective tissue deposition (fibroblastic foci). The degree of alveolar space cellularity, alveolar wall fibrosis, and cellularity did not affect survival. A history of cigarette smoking, the level of dyspnea, and the degree of lung stiffness at presentation were also shown to be independent factors predicting survival. The extent of fibroblastic foci present on lung biopsy predicts survival in IPF. These findings support the hypothesis that the critical pathway to end-stage fibrosis is not “alveolitis” but rather the ongoing epithelial damage and repair process associated with persistent fibroblastic proliferation. Controlling these processes, rather than stopping inflammation, appears most important in preventing progressive disease and the fatal outcome common in IPF.
Mutational and Radiographic Analysis of Pulmonary Disease Consistent with Lymphangioleiomyomatosis and Micronodular Pneumocyte Hyperplasia in Women with Tuberous Sclerosis
Franz, David Neal , Meyer, Cristopher A. , Leonard, Jennifer , Chuck, Gail, Dabora, Sandra L., Sethuraman, Gopalan, Colby, Thomas V. , CORMACK, FRANCIS X. Mc, McCormack, Francis X. , Brody, Alan S. , Kwiatkowski, David J. , McCormack, Francis X

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 164 | Issue: 4 | Pages: 661-668

10.1164/ajrccm.164.4.2011025 | PMID 11520734 Get It

Abstract Lymphangioleiomyomatosis (LAM) and multifocal micronodular pneumocyte hyperplasia (MMPH) produce cystic and nodular disease, respectively, in the lungs of patients with tuberous sclerosis. The objective of this study was to prospectively characterize the prevalence, clinical presentation, and genetic basis of lung disease in TSC. We performed genotyping and computerized tomographic (CT) scanning of the chest on 23 asymptomatic women with tuberous sclerosis complex (TSC). Cystic pulmonary parenchymal changes consistent with LAM were found in nine patients (39%). These patients tended to be older than cyst-negative patients (31.9 ± 7.6 yr versus 24.8 ± 11.6 yr, p = 0.09). There was no correlation between presence of cysts and tobacco use, age at menarche, history of pregnancy, or estrogen-containing medications. Three of the cyst-positive patients had a prior history of pneumothorax. Pulmonary function studies revealed evidence of gas trapping but normal spirometric indices in the cyst-positive group. All nine cyst-positive patients had angiomyolipomas (AML), which were larger (p < 0.05) and more frequently required intervention (p = 0.08) than cyst-negative patients (8 of 14 with AMLs, p < 0.05). Ten patients (43%) had pulmonary parenchymal nodules. Pulmonary nodules were more common in women with cysts (78% versus 21%, p < 0.05), and 52% of all patients had either cystic or nodular changes. TSC2 mutations were identified in all cyst-positive patients who were tested (n = 8), whereas both TSC1 and TSC2 mutations were found in patients with nodular disease. Correlation of the mutational and radiographic data revealed one pair of sisters who were discordant for cystic disease, two mother– daughter pairs who were discordant for nodular disease, and no clear association between cyst development and a specific mutational type. This prospective analysis demonstrates that cystic and nodular pulmonary changes consistent with LAM and MMPH are common in women with TSC.
Idiopathic Pulmonary Fibrosis
Katzenstein, Anna-Luise A., Katzenstein, Anna-Luise A., Myers, Jeffrey L.

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 164 | Issue: 2 | Pages: 185-186

10.1164/ajrccm.164.2.2105010a | PMID 11463582 Get It

Utility of a Lung Biopsy for the Diagnosis of Idiopathic Pulmonary Fibrosis
Hunninghake, Gary W., Zimmerman, M. Bridget, King, Talmadge E. , Lynch, Joseph P., Hegele, Richard G. , Waldron, James A., Colby, Thomas V. , Müller, Néstor L. , Lynch, David A. , Galvin, J R, Gross, Barry H., Hogg, James C. , Toews, Galen, HELMERS, RICK, COOPER, J. ALLEN D., Baughman, Robert P., Millard, Mark, Schwartz, David A. , HELMERS, RICK, Strange, Charlie

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 164 | Issue: 2 | Pages: 193-196

10.1164/ajrccm.164.2.2101090 | PMID 11463586 Get It

Abstract It is not known if a surgical lung biopsy is necessary in all patients for the diagnosis of idiopathic pulmonary fibrosis (IPF). We conducted a blinded, prospective study at eight referring centers. Initially, cases were evaluated by clinical history and examination, transbronchial biopsy, and high-resolution lung computed tomography scans. Pulmonologists at the referring centers then assessed their certainty of the diagnosis of IPF and provided an overall diagnosis, before surgical lung biopsy. The lung biopsies were reviewed by a pathology core and 54 of 91 patients received a pathologic diagnosis of IPF. The positive predictive value of a confident (certain) clinical diagnosis of IPF by the referring centers was 80%. The positive predictive value of a confident clinical diagnosis was higher, when the cases were reviewed by a core of pulmonologists (87%) or radiologists (96%). Lung biopsy was most important for diagnosis in those patients with an uncertain diagnosis and those thought unlikely to have IPF. These studies suggest that clinical and radiologic data that result in a confident diagnosis of IPF by an experienced pulmonologist or radiologist are sufficient to obviate the need for a lung biopsy. Lung biopsy is most helpful when clinical and radiologic data result in an uncertain diagnosis or when patients are thought not to have IPF.
Spiral Computed Tomography Screening for Lung Cancer is Ready for Prime Time
Jett, James R.

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 163 | Issue: 4 | Pages: 812-813

10.1164/ajrccm.163.4.16342a | PMID 11282745 Get It

Temporal Association between Airway Hyperresponsiveness and Airway Eosinophilia in Ovalbumin-Sensitized Mice
Tomkinson, Adrian , Cieslewicz, Grzegorz, Duez, Catherine , Larson, Kirsten A., Lee, J.J., Gelfand, Erwin W., Gelfand, Erwin W.

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 163 | Issue: 3 | Pages: 721-730

10.1164/ajrccm.163.3.2005010 | PMID 11254531 Get It

Abstract The temporal association between airway inflammation and airway hyperresponsiveness (AHR) has been analyzed in BALB/c mice sensitized to, and subsequently exposed to, a single intranasal challenge of ovalbumin (OVA). In OVA-sensitized/challenged animals only a small increase in responsiveness to methacholine (MCh) was seen at 8 h, peaked at 24 to 48 h, and resolved by 96 h. An early bronchoalveolar lavage fluid (BALF) neutrophil infiltrate (peaking at 8 h postchallenge; ∼ 72% total cells was observed) that returned to baseline by 48 h. BALF eosinophil numbers did not increase until 48 h (∼ 32% of total cells), peaked at 96 h (∼ 38% total cells), and remained elevated at 8 d (∼ 27% total cells). Airway tissue eosinophilia preceded changes in BALF. Eosinophil peroxidase (EPO) levels in BALF were elevated in OVA-sensitized/challenged mice at 48 h only. BALF TNF- α levels peaked at 8 h, whereas IL-5 and IL-4 levels peaked at 24 h. IL-13 levels were increased at both 24 and 48 h. Mucus-positive cells were not observed in the airway epithelium until 48 h. Administration of IL-5 or VLA-4 antibody prior to OVA challenge prevented the development of AHR in sensitized mice as well as BALF and tissue eosinophilia. These data identify a temporal association between Th2 cytokine production, tissue eosinophil infiltration and activation, and, importantly, both the development and resolution kinetics of AHR. Moreover, the antibody studies further support the association of eosinophilia with the pathogenesis of AHR.
The Spectrum of Mutations in TSC1 and TSC2 in Women with Tuberous Sclerosis and Lymphangiomyomatosis
STRIZHEVA, GALINA D., Carsillo, Thomas, Kruger, Warren D. , Sullivan, Eugene J., Ryu, Jay H. , HENSKE, ELIZABETH PETRI, Ryu, Jay H

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 163 | Issue: 1 | Pages: 253-258

10.1164/ajrccm.163.1.2005004 | PMID 11208653 Get It

Abstract Lymphangiomyomatosis (LAM) is a progressive and often fatal interstitial lung disease characterized by a diffuse proliferation of abnormal smooth muscle cells in the lungs. LAM is of unusual interest biologically because it affects almost exclusively young women. LAM can occur as an isolated disorder (sporadic LAM) or in association with tuberous sclerosis complex (TSC). Because only a minority of women with TSC develops symptomatic LAM, we hypothesized that a relationship might exist between the type of germline TSC1 or TSC2 gene mutation and the risk of developing LAM. We examined all 41 exons of the TSC2 gene and 21 coding exons of the TSC1 gene for mutations in a group of 14 women with both TSC and LAM using single-strand conformation polymorphism analysis. Seven mutations were found in TSC2 and one in TSC1. Of the seven patients with TSC2 mutations, two had the same in-frame exon 40 deletion and one had an exon 41 missense change. We conclude that germline mutations in the extreme carboxy-terminus of tuberin can result in LAM. Further studies will be required to determine whether mutations in exons 40 and 41 are associated with an increased incidence and/or severity of LAM in women with TSC.
Fibrinogen, Stroke, and Obstructive Sleep Apnea
Shamsuzzaman, Abu, Somers, Virend K.

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 162 | Issue: 6 | Pages: 2018-2020

10.1164/ajrccm.162.6.ed12-00b | PMID 11112100 Get It